Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Cornerstone Planning Group »

Verve Therapeutics shares owned by Cornerstone Planning Group

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Cornerstone Planning Group from 13F filings

Historical chart of Cornerstone Planning Group investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Cornerstone Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Cornerstone Planning Group

Quarter filed	Position value	Share count	Share price at filing
2023-12-31	$28	2	14.00
2023-09-30	$27	2	13.50

More positions owned by Cornerstone Planning Group

Invsc Qqq Trust Srs 1 Etf Iv Exchange Traded Fund (QQQ)

Vanguard Ftse Developed Markets Etf Exchange Traded Fund (VEA)

Schwab Us Dividend Equity Etf Exchange Traded Fund (SCHD)

Ishares Core S&p Small-cap Etf Exchange Traded Fund (IJR)

Ishares Morgstar Mid Capgro Etf Exchange Traded Fund (IMCG)

Vanguard Intermediate Term Bond Etf Exchange Traded Fund (BIV)

Victory Ii Victorysharessrt Etf Iv Exchange Traded Fund (USTB)

Ishares Convertible Bondetf Exchange Traded Fund (ICVT)

Ishares High Yld Bnd Fctetf Exchange Traded Fund (HYDB)

1st Trst Long Shrt Exchange Traded Fund (FTLS)

Ft Emrging Mkts Sml Cap Alphadex Etf Exchange Traded Fund (FEMS)

Ishs Resi And Multi Realestate Etf Exchange Traded Fund (REZ)

Vanguard Mid Cap Value Etf Exchange Traded Fund (VOE)

First Trust Materials Alphadex Etf Exchange Traded Fund (FXZ)

Ishares Russell 1000 Growth Etf Exchange Traded Fund (IWF)

View all positions for Cornerstone Planning Group

Top funds holding Verve Therapeutics

ARK Investment Management

Federated Investors

Sumitomo Mitsui Trust Holdings

Nikko Asset Management Americas

Jpmorgan Chase & Co

Arch Venture Corp

Baker Bros. Advisors

Palo Alto Investors

Citadel Advisors

View all funds holding Verve Therapeutics

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z